News
At Retina World Congress 2025, Dilsher S. Dhoot, MD, shares updates on the HELIOS trial and the potential future of tyrosine ...
The incidence of mild intraocular inflammation (IOI) in the real world occurs more frequently after intravitreal injection of ...
In a new National Institutes of Health-funded study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine ...
New research reveals that hypoglycemia may worsen diabetic retinopathy by breaking down the blood-retinal barrier.
Low blood sugar contributes to eye damage and vision loss in diabetic retinopathy; an experimental drug may help treat the ...
In this Healio Video Perspective from the ARVO meeting, Justis P. Ehlers, MD, shares results from the phase 1 HELIOS study investigating OTX-TKI for the treatment of nonproliferative diabetic ...
In a new National Institutes of Health-funded study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine ...
In a new National Institutes of Health-funded study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have ...
Diabetes is one if the leading causes of preventable vision loss affecting millions of people worldwide, especially the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback